These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate. Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529 [TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy. Vriesendorp PA; Liebregts M; Steggerda RC; Schinkel AF; Willems R; Ten Cate FJ; van Cleemput J; Ten Berg JM; Michels M JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346 [TBL] [Abstract][Full Text] [Related]
26. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies. Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744 [TBL] [Abstract][Full Text] [Related]
27. Causes of death and mortality in hypertrophic cardiomyopathy patients with implantable defibrillators in Sweden. Magnusson P; Gadler F; Liv P; Mörner S J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):478-84. PubMed ID: 26808417 [TBL] [Abstract][Full Text] [Related]
28. Intraoperative management of liver transplantation in patients with hypertrophic cardiomyopathy: a review. Robertson A Transplant Proc; 2010 Jun; 42(5):1721-3. PubMed ID: 20620509 [TBL] [Abstract][Full Text] [Related]
29. Surgical Apgar score is associated with myocardial injury after noncardiac surgery. House LM; Marolen KN; St Jacques PJ; McEvoy MD; Ehrenfeld JM J Clin Anesth; 2016 Nov; 34():395-402. PubMed ID: 27687420 [TBL] [Abstract][Full Text] [Related]
30. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Sorajja P; Ommen SR; Holmes DR; Dearani JA; Rihal CS; Gersh BJ; Lennon RJ; Nishimura RA Circulation; 2012 Nov; 126(20):2374-80. PubMed ID: 23076968 [TBL] [Abstract][Full Text] [Related]
31. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography. Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716 [TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation. Hayashi H; Iwasaki YK; Arai T; Mimuro R; Hachisuka M; Maru Y; Fujimoto Y; Oka E; Hagiwara K; Imori Y; Yamamoto T; Murata H; Yodogawa K; Takano H; Shimizu W Heart Vessels; 2021 May; 36(5):667-674. PubMed ID: 33221953 [TBL] [Abstract][Full Text] [Related]
33. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Kertai MD; Boersma E; Westerhout CM; Klein J; Van Urk H; Bax JJ; Roelandt JR; Poldermans D Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):343-52. PubMed ID: 15350554 [TBL] [Abstract][Full Text] [Related]
34. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy. Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444 [TBL] [Abstract][Full Text] [Related]
35. Patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation: advanced echocardiographic evaluation of the left atrium combined with non-invasive P-wave analysis. Girasis C; Vassilikos V; Efthimiadis GK; Papadopoulou SL; Dakos G; Dalamaga EG; Chouvarda I; Giannakoulas G; Kamperidis V; Paraskevaidis S; Maglaveras N; Karvounis HI; Parcharidis GE; Styliadis IH Eur Heart J Cardiovasc Imaging; 2013 May; 14(5):425-34. PubMed ID: 22902322 [TBL] [Abstract][Full Text] [Related]
36. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. Yashiro B; Minami Y; Terajima Y; Hagiwara N J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311 [TBL] [Abstract][Full Text] [Related]
37. Cardiac risk of noncardiac surgery in patients with asymmetric septal hypertrophy. Haering JM; Comunale ME; Parker RA; Lowenstein E; Douglas PS; Krumholz HM; Manning WJ Anesthesiology; 1996 Aug; 85(2):254-9. PubMed ID: 8712439 [TBL] [Abstract][Full Text] [Related]
38. [Perioperative cardiovascular complications in patients with hypertrophic cardiomyopathy]. Kuroiwa M; Arai M; Ueno T; Takenaka T; Okamoto H; Hoka S Masui; 2003 Jul; 52(7):733-9. PubMed ID: 12910973 [TBL] [Abstract][Full Text] [Related]
39. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Olivotto I; Cecchi F; Casey SA; Dolara A; Traverse JH; Maron BJ Circulation; 2001 Nov; 104(21):2517-24. PubMed ID: 11714644 [TBL] [Abstract][Full Text] [Related]
40. A patient with hypertrophic cardiomyopathy undergoing non-cardiac surgery. Elias TC; Partridge JS; McCorkell SA; Dhesi JK BMJ; 2013 Nov; 347():f6910. PubMed ID: 24277340 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]